Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
44.10
+0.45 (1.03%)
May 16, 2025, 10:32 AM CET

Basilea Pharmaceutica AG Market Cap

Basilea Pharmaceutica AG has a market cap or net worth of 535.50 million as of May 15, 2025. Its market cap has increased by 10.70% in one year.

Market Cap
535.50M
Enterprise Value
526.46M
Revenue
208.54M
Ranking
n/a
PE Ratio
7.49
Stock Price
44.10

Market Cap Chart

Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 535.50M, an increase of 0.41%. That is a compound annual growth rate of 0.02%.

History

DateMarket Cap% Change
May 15, 2025535.50M6.84%
Dec 30, 2024501.21M18.52%
Dec 29, 2023422.90M-22.52%
Dec 30, 2022545.84M12.62%
Dec 30, 2021484.67M-15.59%
Dec 30, 2020574.19M14.12%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Roche Holding AG 207.55B
Novartis AG 176.53B
Lonza Group AG 40.53B
Alcon 39.17B
Galderma Group AG 23.27B
Straumann Holding AG 18.20B
Sandoz Group AG 16.29B
Sonova Holding AG 16.04B
Market Cap Rankings